The diagnosis and management of acute myeloid leukaemia.
Significant advances have been made in the management of AML in younger patients in the last 20 years, and it is easier to identify individual risk groups and stratify treatment accordingly. Results remain discouraging in the elderly, except for the minority with favourable risk factors, and new approaches are needed for most of these patients.
Milligan
D W
DW
Birmingham Heartlands Hospital. d.w.milligan@bham.ac.uk
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D004739:England / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D008875:Middle Aged; D009365:Neoplasm Regression, Spontaneous; D011379:Prognosis; D014184:Transplantation, Homologous; D014852:Wales / Q000453:epidemiology
D000970:Antineoplastic Agents